Literature DB >> 25422487

BRAF mutation and thyroid cancer recurrence.

Mark Yarchoan1, Virginia A LiVolsi1, Marcia S Brose2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25422487     DOI： 10.1200/JCO.2014.59.3657

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  15 in total

1.  Mps1 is associated with the BRAFV600E mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma.

Authors:  Yike Li; Yanyan Zhang; Shuaishuai Xiao; Pengzhou Kong; Caixia Cheng; Ruyi Shi; Fang Wang; Ling Zhang; Juan Wang; Zhiwu Jia; Shuai Wu; Yun Liu; Jiansheng Guo; Xiaolong Cheng; Yongping Cui; Jing Liu
Journal:  Oncol Lett       Date:  2018-04-24       Impact factor: 2.967

Review 2.  BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence.

Authors:  Agnieszka Czarniecka; Małgorzata Oczko-Wojciechowska; Marcin Barczyński
Journal:  Gland Surg       Date:  2016-10

Review 3.  BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers.

Authors:  Jaquelyn N Sanchez; Ton Wang; Mark S Cohen
Journal:  Drugs       Date:  2018-04       Impact factor: 9.546

4.  Genomic profiling of synchronous triple primary tumors of the lung, thyroid and kidney in a young female patient: A case report.

Authors:  Ling Peng; Zhu Zeng; Xiaodong Teng; Zhen Chen; Lili Lin; Hua Bao; Yang W Shao; Yina Wang; Yongquan Dong; Qiong Zhao
Journal:  Oncol Lett       Date:  2018-08-20       Impact factor: 2.967

5.  Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss.

Authors:  Lee Ann Jolly; Sergey Novitskiy; Phillip Owens; Nicole Massoll; Nikki Cheng; Wei Fang; Harold L Moses; Aime T Franco
Journal:  Cancer Res       Date:  2016-01-27       Impact factor: 12.701

6.  The role of palbociclib in thyroid carcinoma with BRAF mutation.

Authors:  Nikolaos Tsoukalas; Konstantinos Tsapakidis; Krystallenia I Alexandraki
Journal:  Gland Surg       Date:  2018-08

7.  Bioinformatics Approach for Prediction of Functional Coding/Noncoding Simple Polymorphisms (SNPs/Indels) in Human BRAF Gene.

Authors:  Mohamed M Hassan; Shaza E Omer; Rahma M Khalf-Allah; Razaz Y Mustafa; Isra S Ali; Sofia B Mohamed
Journal:  Adv Bioinformatics       Date:  2016-07-10

8.  Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis.

Authors:  Chunping Liu; Tianwen Chen; Zeming Liu
Journal:  World J Surg Oncol       Date:  2016-09-06       Impact factor: 2.754

Review 9.  Next-generation sequencing in thyroid cancer.

Authors:  Yoon Jin Cha; Ja Seung Koo
Journal:  J Transl Med       Date:  2016-11-21       Impact factor: 5.531

10.  Activating mutations in BRAF disrupt the hypothalamo-pituitary axis leading to hypopituitarism in mice and humans.

Authors:  Angelica Gualtieri; Nikolina Kyprianou; Louise C Gregory; Maria Lillina Vignola; Mehul T Dattani; Carles Gaston-Massuet; James G Nicholson; Rachael Tan; Shin-Ichi Inoue; Valeria Scagliotti; Pedro Casado; James Blackburn; Fernando Abollo-Jimenez; Eugenia Marinelli; Rachael E J Besser; Wolfgang Högler; I Karen Temple; Justin H Davies; Andrey Gagunashvili; Iain C A F Robinson; Sally A Camper; Shannon W Davis; Pedro R Cutillas; Evelien F Gevers; Yoko Aoki
Journal:  Nat Commun       Date:  2021-04-01       Impact factor: 17.694
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.